Both total and phosphorylated tau are increased in Alzheimer's disease

Por Sjogren, M, Davidsson, P, Tullberg, M, Minthon, L, Wallin, A, Wikkelso, C, Granerus, A, Vanderstichele, H, Vanmechelen, E, Blennow, K
Publicado em 2001

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4

Por Andreasson, U, Lautner, R, Schott, J M, Mattsson, N, Hansson, O, Herukka, S-K, Helisalmi, S, Ewers, M, Hampel, H, Wallin, A, Minthon, L, Hardy, J, Blennow, K, Zetterberg, H
Publicado em 2014

Development of Screening Guidelines and Clinical Criteria for Predementia Alzheimer's Disease: The DESCRIPA Study

Por Visser, P.J., Verhey, F.R.J., Boada, M., Bullock, R., De Deyn, P.P., Frisoni, G.B., Frölich, L., Hampel, H., Jolles, J., Jones, R., Minthon, L., Nobili, F., Olde Rikkert, M., Ousset, P.-J., Rigaud, A.-S., Scheltens, P., Soininen, H., Spiru, L., Touchon, J., Tsolaki, M., Vellas, B., Wahlund, L.-O, Wilcock, G., Winblad, B.
Publicado em 2008

Age and diagnostic performance of Alzheimer disease CSF biomarkers

Por Mattsson, N., Rosén, E., Hansson, O., Andreasen, N., Parnetti, L., Jonsson, M., Herukka, S.-K., van der Flier, W.M., Blankenstein, M.A., Ewers, M., Rich, K., Kaiser, E., Verbeek, M.M., Olde Rikkert, M., Tsolaki, M., Mulugeta, E., Aarsland, D., Visser, P.J., Schröder, J., Marcusson, J., de Leon, M., Hampel, H., Scheltens, P., Wallin, A., Eriksdotter-Jönhagen, M., Minthon, L., Winblad, B., Blennow, K., Zetterberg, H.
Publicado em 2012